Search results
In 2020, Occam placed John Reynders, PhD, as the company's first Chief Data Sciences Officer. Prior to Neumora, John served as Vice President, data sciences, genomics and bioinformatics at Alexion, where he led the design, building and deployment of data sciences solutions spanning R&D, commercial, strategy and business development.
John Reynders, PhD MBA, is the Chief Data Sciences Officer of a private stealth biotech. John is also the founder and CEO of Latent Strategies, LLC, an AI start-up applying data sciences and game theory to business strategy and education.
With over 25 years of leadership experience in life sciences, data-sciences, and technology in organizations spanning early-stage biotechs, multi-national pharmaceuticals, and a top U.S national research laboratory, John Reynders established Reynders Consulting in 2020.
- Director
- Global Genes, Global Genes
Oct 7, 2021 · Chief Research Officer Nick Brandon, for example, helped lead neuroscience research at Pfizer and AstraZeneca, whereas Chief Data Science Officer John Reynders was previously Moderna's first chief information officer and a vice president of data sciences, genomics and bioinformatics at Alexion Pharmaceuticals.
Jul 10, 2019 · A new sunrise, a new beginning. John Reynders. CEO TSH. Published Jul 10, 2019. + Follow. More than fourteen years ago I joined Microsoft with the ambition to learn and grow by being surrounded...
View John Reynders’ profile on LinkedIn, a professional community of 1 billion members. Experience: Latent Strategies, LLC · Location: Greater Boston · 500+ connections on LinkedIn.
- Latent Strategies, LLC
President John C. Reynders Morningside College President John Reynders has announced his plans to retire effective June 30, 2021. Reynders was named Morningside’s 12 th president in 1999 and became the college’s longest-serving president in 2019.
